Get started
Author

Simona Bruzas

Observed names: Bruzas, Simona, S Bruzas, S. Bruzas, S. Bruz̆as
OpenAlex ID: A5013039209
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy
2024 · Giacomo Montagna, Mary M. Mrdutt, et al. · JAMA Oncology · 98
PDF
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer
2023 · Sherko Kuemmel, Joerg Heil, et al. · JAMA Surgery · 87
Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
2023 · Mattea Reinisch, Simona Bruzas, et al. · Therapeutic Advances in Medical Oncology · 37
The value of MMP-9 for breast and non-small cell lung cancer patients' survival
2013 · D Schveigert, S Cicenas, et al. · Advances in Medical Sciences · 30
Abstract GS4-02: Oncological Outcomes Following Omission of Axillary Lymph Node Dissection in Node Positive Patients Downstaging To Node Negative with Neoadjuvant Chemotherapy: the OPBC-04/EUBREAST-06/OMA study
2023 · Giacomo Montagna, Mary Mrdutt, et al. · Cancer Research · 20
Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice
2021 · Simona Bruzas, Sherko Kuemmel, et al. · Cancers · 19
PDF
Gene signatures in patients with early breast cancer and relapse despite pathologic complete response
2022 · Simona Bruzas, Oleg Gluz, et al. · npj Breast Cancer · 11
PDF
Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers
2021 · Mattea Reinisch, Sherko Kuemmel, et al. · Orphanet Journal of Rare Diseases · 4
PDF
Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy
2023 · Mattea Reinisch, Simona Bruzas, et al. · Molecular Oncology · 2
PDF
Author response for "Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy"
2022 · Mattea Reinisch, Simona Bruzas, et al.
201TiP Evaluation of the feasibility of ultrasound-guided clipping of suspicious intramammary lesions in primary breast cancer patients receiving neoadjuvant therapy (Ultra3Detect)
2021 · E. Vlachou, S. Kümmel, et al. · Annals of Oncology
Olaparib in metastatic breast cancer accompanied by germline PALB2 mutations: 2 case reports
2021 · H Harach, S Kuemmel, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
172P Gene expression in early breast cancer (EBC) patients (pts) with relapse despite pathologic complete response (pCR): An intra- and interindividual (matched control) analysis
2020 · S. Bruzas, S. Kümmel, et al. · Annals of Oncology
Metastatic and recurrent, malignant breast phyllodes tumors harbor aberrations in genes frequently altered in other advanced neoplasms
2020 · S Bruzas, E Breit, et al. · Geburtshilfe und Frauenheilkunde
Metastatic and recurrent, malignant breast phyllodes tumors harbor aberrations in genes frequently altered in other advanced neoplasms
2020 · S Bruzas, E Breit, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Abstract PD5-09: Prognostic and predictive impact of genes and signatures measured with the BC360 panel (Nanostring) in node positive (≥pN2a) high risk patients (pts) receiving dose dense (dd) versus standard dosed chemotherapy in an adjuvant randomized trial with a long term follow-up (FU)
2020 · Mattea Reinisch, Oleg Gluz, et al. · Cancer Research
P225 Results of combined treatment of breast oncoplastic operations
2011 · V. Ostapenko, A. Mudenas, et al. · The Breast
PDF
266 The follow-up results of treatment of male breast carcinoma
2010 · A. Jackevicius, A. Mudenas, et al. · European Journal of Cancer Supplements
Value ER, PR and HER Status as Independent Prognostic Factor of Local Recurrence after Breast Conserving Surgery.
2009 · V. Ostapenko, S. Bruzas, et al. · Cancer Research
0053 Local recurrence rates after breast conserving surgery according to age, location, ER, PR and HER status
2009 · V. Ostapenko, S. Bruzas, et al. · The Breast
Value of latissimus dorsi flap (LDF) in breast conserving surgery (BCS)
2008 · S. Bruzas, A. Mudenas, et al. · European Journal of Cancer Supplements
P79 Five year results of Breast Conserving Surgery for early breast cancer patients
2007 · V. Ostapenko, S. Bruzas, et al. · The Breast
P125 Treatment of male breast cancer
2005 · A. Mudenas, A. Jackevicius, et al. · The Breast
P56 Value of axillary dissection technique in combined treatment of Breast Cancer patients
2005 · V. Ostapenko, S. Bruzas, et al. · The Breast
Clinical features of male breast cancer
2003 · A. Mudenas, A. Jackevicius, et al. · The Breast
Works count: 30
Citation count: 308
H-index: 7
I10-index: 7
Year
Topic
Type